Clinical trial
Fabry Disease Registry Protocol
NCT00196742 is registered in ClinicalTrials.gov with Genzyme, a Sanofi Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fabry Disease Registry Protocol
- Lead sponsor
- Genzyme, a Sanofi Company
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 31, 2001
- Completion date
- January 31, 2034
- Enrollment
- 9,000 (estimated)
- Sites
- 284
Conditions
As the registry lists them; a condition with its own page is linked.